Related Experiment Videos
[Bilateral optic neuropathy following amiodarone therapy]
1Augenklinik Kantonsspital Luzern.
Klinische Monatsblatter Fur Augenheilkunde
|February 1, 1992
Summary
Amiodarone-induced optic neuropathy is rare, with only 17 cases reported. This case study details optic atrophy in a patient treated with amiodarone, highlighting irreversible vision loss.
Area of Science:
- Ophthalmology
- Neurology
Background:
- Amiodarone is an antiarrhythmic drug with known potential ocular side effects.
- Optic neuropathy is a rare but serious complication associated with amiodarone treatment.
Observation:
- A 62-year-old patient developed optic atrophy with decreased visual acuity and visual field defects in the left eye during amiodarone therapy.
- The right eye showed optic disc swelling that progressed to optic atrophy with irreversible visual impairment after discontinuing amiodarone.
Findings:
- The patient experienced bilateral optic atrophy, decreased visual acuity, and severe visual field defects.
- The condition resulted in irreversible vision loss in both eyes.
Implications:
- This case underscores the importance of monitoring visual function in patients receiving amiodarone.
- Early detection and discontinuation of amiodarone may be crucial in managing or preventing severe visual outcomes.
- Further research is needed to understand the pathophysiology and risk factors for amiodarone-induced optic neuropathy.